Aurobindo’s Latest Launches Include Truvada And Atripla Rivals

As Company Plans To Broaden Its Injectables Generics Portfolio In China

manufacturing facility
Aurobindo is setting up a dedicated manufacturing facility for Europe and the RoW markets in Visakhapatnam India. • Source: Shutterstock

More from Products

More from Generics Bulletin